Study Approval
The study was approved by the Ethics Committee of University Hospital
Essen (21-9998_1-KOBO, 20-9791-BO & 22-10581-BO). Written informed
consent was obtained from all participants.
References
- Fainardi V, Meoli A, Chiopris G, Motta M, Skenderaj K, Grandinetti R,
et al. Long COVID in Children and Adolescents. Life 2022;12:285. doi:
10.3390/life12020285
- Mehta NS, Mytton OT, Mullins EWS, Fowler TA, Falconer CL, Murphy OB,
et al. SARS-CoV-2 (COVID-19): What Do We Know About Children? A
Systematic Review. Clin Infect Dis 2020;71:2469–79. doi:
10.1093/cid/ciaa556
- Fialkowski A, Gernez Y, Arya P, Weinacht KG, Kinane TB, Yonker LM.
Insight into the pediatric and adult dichotomy of COVID-19:
Age-related differences in the immune response to SARS-CoV-2
infection. Pediatr Pulmonol 2020;55:2556–64. doi: 10.1002/ppul.24981
- Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al.
The immunology of multisystem inflammatory syndrome in children with
COVID-19. Cell 2020;183:968-981.e7. doi: 10.1016/j.cell.2020.09.016
- Bogunovic D, Merad M. Children and SARS-CoV-2. Cell Host Microbe
2021;29:1040–2. doi: 10.1016/j.chom.2021.06.015
- Sorg AL, Becht S, Jank M, Armann J, von Both U, Hufnagel M, et al.
Association of SARS-CoV-2 seropositivity with myalgic
encephalomyelitis and/or chronic fatigue syndrome among children and
adolescents in germany. JAMA Netw Open 2022;5:e2233454–e2233454. doi:
10.1001/jamanetworkopen.2022.33454.
- Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long
COVID symptoms and duration in SARS-CoV-2 positive children — a
nationwide cohort study. Eur J Pediatr 2022;181:1597–607. doi:
10.1007/s00431-021-04345-z
- Leftin Dobkin SC, Collaco JM, McGrath-Morrow SA. Protracted
respiratory findings in children post-SARS-CoV-2 infection. Pediatr
Pulmonol 2021;56:3682–7. doi: 10.1002/ppul.25671.
- Ortona E, Malorni W. Long COVID: to investigate immunological
mechanisms and sex/gender related aspects as fundamental steps for
tailored therapy. Eur Respir J 2022;59:2102245. doi:
10.1183/13993003.02245-2021
- Rao S, Lee GM, Razzaghi H, Lorman V, Mejias A, Pajor NM, et al.
Clinical Features and Burden of postacute sequelae of SARS-CoV-2
infection in children and adolescents. JAMA Pediatr 2022;176:1000–9.
doi: 10.1001/jamapediatrics.2022.2800
- Lopez-Leon S, Wegman-Ostrosky T, Ayuzo del Valle NC, Perelman C,
Sepulveda R, Rebolledo PA, et al. Long-COVID in children and
adolescents: a systematic review and meta-analyses. Sci Rep
2022;12:9950. doi: 10.1038/s41598-022-13495-5
- Kikkenborg Berg S, Palm P, Nygaard U, Bundgaard H, Petersen MNS,
Rosenkilde S, et al. Long COVID symptoms in SARS-CoV-2-positive
children aged 0–14 years and matched controls in Denmark
(LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child
Adolesc Health 2022;6:614–23. doi: 10.1016/S2352-4642(22)00154-7
- Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et
al. Characterising long COVID: a living systematic review. BMJ Glob
Health 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427
- Funk AL, Kuppermann N, Florin TA, Tancredi DJ, Xie J, Kim K, et al.
Post–COVID-19 conditions among children 90 days after sars-cov-2
infection. JAMA Netw Open 2022;5:e2223253–e2223253. doi:
10.1001/jamanetworkopen.2022.23253
- Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early
factors anticipate post-acute COVID-19 sequelae. Cell
2022;185:881-895.e20. doi: 10.1016/j.cell.2022.01.014
- Grandjean L, Saso A, Torres Ortiz A, Lam T, Hatcher J, Thistlethwayte
R, et al. Long-term persistence of spike protein antibody and
predictive modeling of antibody dynamics after infection with severe
acute respiratory syndrome coronavirus 2. Clin Infect Dis
2022;74:1220–9 doi: 10.1093/cid/ciab607
- Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute
infection syndromes. Nat Med 2022;28:911–23. doi:
10.1038/s41591-022-01810-6
- Koczulla A, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F,
et al. S1-Leitlinie Post-COVID/Long-COVID. Pneumologie
2021;75:869-900. doi: 10.1055/a-1551-9734
- Venkatesan P. NICE guideline on long COVID. Lancet Respir Med.
2021;9:129. doi: 10.1016/S2213-2600(21)00031-X
- Brasseler M, Schönecker A, Steindor M, Della Marina A, Bruns N, Dogan
B, et al. Development of restrictive eating disorders in children and
adolescents with long-COVID-associated smell and taste dysfunction.
Front Pediatr 2022;10:1022669. doi: 10.3389/fped.2022.1022669
- Thieme CJ, Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A,
Seibert FS, et al. Robust T cell response toward spike, membrane, and
nucleocapsid SARS-CoV-2 Proteins is not associated with recovery in
critical COVID-19 patients. Cell Rep Med 2020;1:100092. doi:
10.1016/j.xcrm.2020.100092.
- Paniskaki K, Anft M, Meister TL, Marheinecke C, Pfaender S, Skrzypczyk
S, et al. Immune response in moderate to critical breakthrough
COVID-19 infection after mRNA vaccination. Front
Immunol 2022;13:816220. doi: 10.3389/fimmu.2022.816220
- Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert FS,
Hölzer B, et al. COVID-19-induced ARDS is associated with decreased
frequency of activated memory/effector T cells expressing CD11a++. Mol
Ther 2020;28:2691–702. doi: 10.1016/j.ymthe.2020.10.001
- Loyal L, Braun J, Henze L, Kruse B, Dingeldey M, Reimer U, et al.
Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon
infection and vaccination. Science 2021;374:eabh1823. doi:
10.1126/science.abh1823
- Paniskaki K, Konik MJ, Anft M, Meister TL, Marheinecke C, Pfaender S,
et al. Superior humoral immunity in vaccinated SARS-CoV-2
convalescence as compared to SARS-COV-2 infection or vaccination.
Front Immunol 2022;13:1031254. doi: 10.3389/fimmu.2022.1031254
- Kent SJ, Khoury DS, Reynaldi A, Juno JA, Wheatley AK, Stadler E, et
al. Disentangling the relative importance of T cell responses in
COVID-19: leading actors or supporting cast? Nat Rev Immunol 2022;
22:387-397. doi:10.1038/s41577-022-00716-1
- Finlay JB, Brann DH, Abi Hachem R, Jang DW, Oliva AD, Ko T, et al.
Persistent post–COVID-19 smell loss is associated with immune cell
infiltration and altered gene expression in olfactory epithelium. Sci
Transl Med 2022;14:eadd0484. doi: 10.1126/scitranslmed.add0484
- Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, et al. Immune
signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol
2021;6:eabk1741. doi: 10.1126/sciimmunol.abk1741
- Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et
al. Immunological dysfunction persists for 8 months following initial
mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022;23:210–6.
doi: 10.1038/s41590-021-01113-x.
- Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M,
et al. SARS-CoV-2-specific T cells associate with inflammation and
reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.
PLoS Pathog 2022;18: e1010359. doi: 10.1371/journal.ppat.1010359
- Bacher P, Rosati E, Esser D, Martini GR, Saggau C, Schiminsky E, et
al. Low-avidity CD4+ T cell responses to SARS-CoV-2 in unexposed
individuals and humans with severe COVID-19. Immunity
2020;53:1258-1271.e5. doi: 10.1016/j.immuni.2020.11.016
- Paniskaki K, Konik MJ, Anft M, Heidecke H, Meister TL, Pfaender S, et
al. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with
proinflammatory TEMRA phenotype are associated with post-acute
sequelae of COVID-19. Front Microbiol 2023;14:1196721. doi:
10.3389/fmicb.2023.1196721
- Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Trivella JP, et
al. Post–Covid-19 cholangiopathy—A new indication for liver
transplantation: A case report. Transplant Proc. 2021;53:1132–7. doi:
10.1016/j.transproceed.2021.03.007
- Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, et al.
Post–COVID-19 Cholangiopathy: A Novel Entity. Am J Gastroenterol
2021;116:1077-1082. doi:10.14309/ajg.0000000000001154
- Cooper S, Tobar A, Konen O, Orenstein N, Kropach Gilad N, Landau YE,
et al. Long COVID-19 liver manifestation in children. J Pediatr
Gastroenterol Nutr 2022;75:244-251. doi: 10.1097/MPG.0000000000003521
- Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodríguez Y, Zapata E,
Ramírez-Santana C, et al. Persistent autoimmune activation and
proinflammatory state in post-coronavirus disease 2019 syndrome. J
Infect Dis 2022;225:2155–62. doi: 10.1093/infdis/jiac017
- Lee CH, Giuliani F. The role of inflammation in depression and
fatigue. Front Immunol. 2019;10:1696. doi: 10.3389/fimmu.2019.01696
- Klimas NG, Broderick G, Fletcher MA. Biomarkers for chronic fatigue.
Brain Behav Immun. 2012;26:1202–10. doi: 10.1016/j.bbi.2012.06.006
- Raison CL, Lin JMS, Reeves WC. Association of peripheral inflammatory
markers with chronic fatigue in a population-based sample. Brain Behav
Immun 2009;23:327–37. doi: 10.1016/j.bbi.2008.11.005
- Pedraz-Petrozzi B, Neumann E, Sammer G. Pro-inflammatory markers and
fatigue in patients with depression: A case-control study. Sci Rep
2020;10:9494. doi: 10.1038/s41598-020-66532-6
- Fernández-Castañeda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et
al. Mild respiratory COVID can cause multi-lineage neural cell and
myelin dysregulation. Cell 2022;185:2452-2468.e16. doi:
10.1016/j.cell.2022.06.008
- Etter MM, Martins TA, Kulsvehagen L, Pössnecker E, Duchemin W, Hogan
S, et al. Severe Neuro-COVID is associated with peripheral immune
signatures, autoimmunity and neurodegeneration: a prospective
cross-sectional study. Nat Commun 2022;13:6777.
doi:10.1038/s41467-022-34068-0
- Kiho S, Rameen J, Abhiroop C, Manan M, Carmen V, Kate M, et al.
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict
long COVID symptoms. Eur Respir J 2023;61:2200970. doi:
10.1183/13993003.00970-2022
Tables
Table 1: Demographic characteristics of the study cohorts